INDIA – CureBay, a healthcare startup in India, has raised US$ 21 million in its Series B funding round to expand its services to rural areas using artificial intelligence (AI).
The funding was led by Bertelsmann India Investment, with support from Elevar Equity and British International Investment.
Launched in 2021, CureBay has built a network of over 150 e-clinics in Odisha and Chhattisgarh. These clinics are supported by more than 1,000 trained community health workers, known as Swasthya Mitras.
They assist patients with teleconsultations, lab tests, medication ordering and administration, hospital admissions, and more. So far, about 90,000 people have signed up for its preventive health services.
With this new funding, CureBay plans to use advanced AI tools to improve its clinic operations. These include machine learning, generative AI, and Internet of Things (IoT) devices, which aim to make healthcare services smarter and faster.
The company’s custom-built AI algorithms will automate workflows and help predict patient needs more accurately.
Founder and CEO Priyadarshi Mohapatra stated that the new investment will enable CureBay to expand its technology, team, and clinic reach, making affordable and respectful healthcare accessible in the most remote parts of India. CureBay aims to grow its network to 200 rural clinics.
This funding comes at a time when AI-focused health startups in India are attracting serious investor interest.
Qure.ai recently raised US$ 65 million for its medical imaging AI tools, while Cureskin secured US$ 20 million for its AI-based skincare platform.
Other startups, such as Dozee and BrainSight AI, are also utilizing AI to develop tools for non-contact health monitoring and mapping brain functions.